Jun. 24 at 1:24 AM
On September 15, 2022,
$SPRO held its AGM. One proposal was to increase the shares under the 2017 stock incentive comp plan by 2 million shares.
On Sept 21, 2022,
$SPRO and
$GSK entered into the license agreement we are considering today -- 6 days after that September AGM.
I don't think the new shares were registered for employees until November 14, 2022 (2 months after the AGM).
Perhaps now that SPRO/GSK have known each other for nearly 4 years, have the FDA approval in hand, the incremental 120 million share authorized, and the S-8 registration statement for employee stock comp (retention RSUs??)...
Could they have pulled the trigger on everything the same day as the AGM -- or need 6(ish) calendar days to close biz?
If they've been working on deals in parallel and the FDA + share authorization + SPRO comp were the unlocks, perhaps?
